W. S. McDougal, MD

Massachusetts General Hospital

Massachusetts General Hospital
Phone: (617) 726-3010
Fax: (617) 726-6131


wmcdougal@partners.org

W. S. McDougal, MD

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Walter S. Kerr, Jr. Distinguished Professor of Urology, Surgery, Harvard Medical School
  • Chief, Urology, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

Research focus is genitourinary cancer and urinary intestinal diversion. Metabolic problems of diversion.

Publications

Powered by Harvard Catalyst
  • Preston MA, Feldman AS, Coen JJ, McDougal WS, Smith MR, Paly JJ, Carrasquillo R, Wu CL, Dahl DM, Barrisford GW, Blute ML, Zietman AI. Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urol Oncol 2015. PubMed
  • Eswara JR, Heney NM, Wu CL, McDougal WS. Long-Term Outcomes of Organ Preservation in Patients with Small Cell Carcinoma of the Bladder. Urol. Int. 2015. PubMed
  • Talab SS, McDougal WS, Wu CL, Tabatabaei S. Mucosa-sparing, KTP Laser Coagulation of Submucosal Telangiectatic Vessels in Patients With Radiation-induced Cystitis: A Novel Approach. Urology 2014. PubMed
  • Sharron Lin X, Hu L, Sandy K, Correll M, Quackenbush J, Wu CL, Scott McDougal W. Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: Applying RNA-sequencing analysis on archived specimens. Urol Oncol 2014; 32:327-36. PubMed
  • McDougal WS, Lee RJ, Efstathiou JA, Harisinghani M, Wu CL. Case records of the Massachusetts General Hospital. Case 2-2014. A 44-year-old man with a lesion on the penis. N Engl J Med 2014; 370:263-71. PubMed
  • Eswara JR, McDougal WS. Long-term outcomes of surgical management for nonmalignant perineal disease. J Urol 2013; 190:2139-43. PubMed
  • Dong F, Yang P, Wang C, Wu S, Xiao Y, McDougal WS, Young RH, Wu CL. Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma. Am J Surg Pathol 2013; 37:1855-61. PubMed
  • Cai C, Zhong WD, McDougal WS, Wu CL. A 32-gene risk index: a new prognostic approach for prostate cancer progression. Asian J. Androl. 2013; 15:590-1. PubMed
  • Hegarty PK, Eardley I, Heidenreich A, McDougal WS, Minhas S, Spiess PE, Watkin N, Horenblas S. Penile Cancer: Organ-sparing techniques. BJU Int 2013. PubMed
  • Wu CL, Schroeder BE, Ma XJ, Cutie CJ, Wu S, Salunga R, Zhang Y, Kattan MW, Schnabel CA, Erlander MG, McDougal WS. Development and validation of a 32-gene prognostic index for prostate cancer progression. Proc Natl Acad Sci U S A 2013; 110:6121-6. PubMed
  • Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63:486-92. PubMed
  • Chekaluk Y, Wu CL, Rosenberg J, Riester M, Dai Q, Lin S, Guo Y, McDougal WS, Kwiatkowski DJ. Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value. PLoS ONE 2013; 8:e60927. PubMed
  • Lu J, Wirth GJ, Wu S, Chen J, Dahl DM, Olumi AF, Young RH, McDougal WS, Wu CL. A close surgical margin after radical prostatectomy is an independent predictor of recurrence. J Urol 2012; 188:91-7. PubMed
  • Psutka SP, Feldman AS, Rodin D, Olumi AF, Wu CL, McDougal WS. Men With Organ-confined Prostate Cancer and Positive Surgical Margins Develop Biochemical Failure at a Similar Rate to Men With Extracapsular Extension. Urology 2011. PubMed
  • Maxeiner A, Adkins CB, Zhang Y, Taupitz M, Halpern EF, McDougal WS, Wu CL, Cheng LL. Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles. Prostate 2010; 70:710-7. PubMed
  • Kaul D, Wu CL, Adkins CB, Jordan KW, Defeo EM, Habbel P, Peterson RT, McDougal WS, Pohl U, Cheng LL. Assessing prostate cancer growth with mRNA of spermine metabolic enzymes. Cancer Biol Ther 2010; 9:736-42. PubMed
  • McDougal WS. Editorial comment. J Urol 2010; 183:902; discussion 902. PubMed
  • Wu CL, Jordan KW, Ratai EM, Sheng J, Adkins CB, Defeo EM, Jenkins BG, Ying L, McDougal WS, Cheng LL. Metabolomic imaging for human prostate cancer detection. Sci Transl Med 2010; 2:16ra8. PubMed
  • McDougal WS. Editorial comment. J Urol 2009; 183:55. PubMed
  • McDougal WS. Editorial comment. J Urol 2009; 182:1293; discussion 1293. PubMed
  • Kaufman DS, McDougal WS, Harisinghani MG, Wu CL. Case records of the Massachusetts General Hospital. Case 30-2009. A 77-year-old man with recurrent transitional-cell carcinoma of the ureter. N Engl J Med 2009; 361:1292-9. PubMed
  • Dahl DM, Barry MJ, McGovern FJ, Chang Y, Walker-Corkery E, McDougal WS. A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy. J Urol 2009; 182:956-65. PubMed
  • Feldman AS,Banyard J,Wu CL,McDougal WS,Zetter BR. Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin Cancer Res 2009; 15:1024-31. PubMed
  • Zhang H,Zhang Y,Duan HO,Kirley SD,Lin SX,McDougal WS,Xiao H,Wu CL. TIP30 is associated with progression and metastasis of prostate cancer. Int J Cancer 2008; 123:810-6. PubMed
  • Connolly SS, Yoo JJ, Abouheba M, Soker S, McDougal WS, Atala A. Cavernous nerve regeneration using acellular nerve grafts. World J Urol 2008; 26:333-9. PubMed
  • Guimaraes AR, Tabatabei S, Dahl D, McDougal WS, Weissleder R, Harisinghani MG. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology 2008; 71:708-12. PubMed
  • Feldman AS, McDougal WS, Harisinghani MG. The potential of nanoparticle-enhanced imaging. Urol Oncol 2008; 26:65-73. PubMed
  • Kaufman DS, McDougal WS, Zietman AL, Young RH. Case records of the Massachusetts General Hospital. Case 18-2007. A 54-year-old man with early-stage prostate cancer. N Engl J Med 2007; 356:2515-20. PubMed
  • Dahl DM, He W, Lazarus R, McDougal WS, Wu CL. Pathologic outcome of laparoscopic and open radical prostatectomy. Urology 2006; 68:1253-6. PubMed
  • McDougal WS, Tolkoff-Rubin NE, Michaelson MD, Mueller PR, Braaten K. Case records of the Massachusetts General Hospital. Case 28-2006. A 59-year-old man with masses in both kidneys. N Engl J Med 2006; 355:1161-7. PubMed
  • Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005; 185:72-80. PubMed
  • Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185:64-71. PubMed
  • Kalish LA, McDougal WS, McKinlay JB. Family history and the risk of prostate cancer. Urology 2000; 56:803-6. PubMed
  • Planz B, Aretz HT, Wang Q, Tabatabaei S, Kirley SD, Lin CW, McDougal WS. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Prostate 1999; 41:233-42. PubMed
  • Grocela JA, McDougal WS. Ammonium transport in the intestine chronically exposed to urine: is it reduced over time? Urology 1999; 54:373-6. PubMed
  • Planz B, Kirley SD, Wang Q, Tabatabaei S, Aretz HT, McDougal WS. Characterization of a stromal cell model of the human benign and malignant prostate from explant culture. J Urol 1999; 161:1329-36. PubMed
  • Stampfer DS, McDougal WS. Inhibition of the sodium/hydrogen antiport by ammonium ion. J Urol 1997; 157:362-5. PubMed
Hide